Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.1601
+0.0051 (3.29%)
Mar 31, 2025, 3:34 PM EST

Bio-Path Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Selling, General & Admin
4.74.244.744.534.33
Upgrade
Research & Development
7.311.619.175.916.58
Upgrade
Operating Expenses
11.9915.8413.910.4410.91
Upgrade
Operating Income
-11.99-15.84-13.9-10.44-10.91
Upgrade
Interest & Investment Income
0.010.040.0300.03
Upgrade
Other Non Operating Income (Expenses)
2.08-0.27---
Upgrade
EBT Excluding Unusual Items
-9.89-16.08-13.87-10.44-10.88
Upgrade
Pretax Income
-9.89-16.08-13.87-10.44-10.88
Upgrade
Net Income
-9.89-16.08-13.87-10.44-10.88
Upgrade
Net Income to Common
-9.89-16.08-13.87-10.44-10.88
Upgrade
Shares Outstanding (Basic)
20000
Upgrade
Shares Outstanding (Diluted)
20000
Upgrade
Shares Change (YoY)
402.30%31.32%8.25%74.81%44.79%
Upgrade
EPS (Basic)
-4.12-33.64-38.10-31.05-56.57
Upgrade
EPS (Diluted)
-4.12-33.64-38.12-31.05-56.57
Upgrade
Free Cash Flow
-10.58-11.54-15.12-9.99-10.96
Upgrade
Free Cash Flow Per Share
-4.40-24.13-41.55-29.70-56.98
Upgrade
EBITDA
-11.94-15.76-13.81-10.37-10.84
Upgrade
D&A For EBITDA
0.050.080.090.080.07
Upgrade
EBIT
-11.99-15.84-13.9-10.44-10.91
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.